Cite

HARVARD Citation

    Brighi, N. et al. (2019). Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study. Digestive and liver disease. 51 (5), pp. 689-694. [Online]. 
  
Back to record